Truist Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,823
| Closed | -$3.46M | – | 2824 |
|
|
2021
Q2 | $3.46M | Sell |
18,823
-7,950
| -30% | -$1.46M | 0.01% | 1031 |
|
|
2021
Q1 | $4.09M | Sell |
26,773
-41,122
| -61% | -$6.29M | 0.01% | 922 |
|
|
2020
Q4 | $10.6M | Buy |
67,895
+45,866
| +208% | +$7.17M | 0.02% | 581 |
|
|
2020
Q3 | $2.52M | Sell |
22,029
-103,220
| -82% | -$11.8M | 0.01% | 982 |
|
|
2020
Q2 | $14.1M | Sell |
125,249
-3,292
| -3% | -$370K | 0.03% | 445 |
|
|
2020
Q1 | $11.5M | Buy |
128,541
+107,265
| +504% | +$9.63M | 0.03% | 459 |
|
|
2019
Q4 | $2.3M | Buy |
21,276
+15,740
| +284% | +$1.7M | ﹤0.01% | 1064 |
|
|
2019
Q3 | $543K | Sell |
5,536
-704
| -11% | -$69.1K | 0.01% | 554 |
|
|
2019
Q2 | $817K | Buy |
6,240
+41
| +0.7% | +$5.37K | 0.01% | 489 |
|
|
2019
Q1 | $838K | Buy |
6,199
+340
| +6% | +$46K | 0.02% | 491 |
|
|
2018
Q4 | $571K | Sell |
5,859
-1,218
| -17% | -$119K | 0.01% | 536 |
|
|
2018
Q3 | $984K | Buy |
7,077
+428
| +6% | +$59.5K | 0.02% | 479 |
|
|
2018
Q2 | $825K | Sell |
6,649
-101
| -1% | -$12.5K | 0.02% | 506 |
|
|
2018
Q1 | $752K | Buy |
6,750
+798
| +13% | +$88.9K | 0.01% | 508 |
|
|
2017
Q4 | $712K | Sell |
5,952
-219
| -4% | -$26.2K | 0.01% | 530 |
|
|
2017
Q3 | $866K | Buy |
6,171
+463
| +8% | +$65K | 0.02% | 491 |
|
|
2017
Q2 | $695K | Buy |
5,708
+364
| +7% | +$44.3K | 0.01% | 520 |
|
|
2017
Q1 | $648K | Buy |
+5,344
| New | +$648K | 0.01% | 539 |
|